306 related articles for article (PubMed ID: 29544512)
1. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
[TBL] [Abstract][Full Text] [Related]
2. Correlation between gamma index passing rate and clinical dosimetric difference for pre-treatment 2D and 3D volumetric modulated arc therapy dosimetric verification.
Jin X; Yan H; Han C; Zhou Y; Yi J; Xie C
Br J Radiol; 2015 Mar; 88(1047):20140577. PubMed ID: 25494412
[TBL] [Abstract][Full Text] [Related]
3.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram.
Stasi M; Bresciani S; Miranti A; Maggio A; Sapino V; Gabriele P
Med Phys; 2012 Dec; 39(12):7626-34. PubMed ID: 23231310
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 3D anatomical dose verification and 2D phantom dose verification of IMRT/VMAT treatments for nasopharyngeal carcinoma.
Lin H; Huang S; Deng X; Zhu J; Chen L
Radiat Oncol; 2014 Mar; 9():71. PubMed ID: 24606879
[TBL] [Abstract][Full Text] [Related]
7. A novel approach to EPID-based 3D volumetric dosimetry for IMRT and VMAT QA.
Alhazmi A; Gianoli C; Neppl S; Martins J; Veloza S; Podesta M; Verhaegen F; Reiner M; Belka C; Parodi K
Phys Med Biol; 2018 May; 63(11):115002. PubMed ID: 29714714
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
9. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
10. Development of a quasi-3D dosimeter using radiochromic plastic for patient-specific quality assurance.
Cho JD; Jin H; Jung S; Son J; Choi CH; Park JM; Kim JS; Kim JI
Med Phys; 2023 Oct; 50(10):6624-6636. PubMed ID: 37408321
[TBL] [Abstract][Full Text] [Related]
11. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
12. A study on the effect of detector resolution on gamma index passing rate for VMAT and IMRT QA.
Woon W; Ravindran PB; Ekayanake P; S V; Lim YY; Khalid J
J Appl Clin Med Phys; 2018 Mar; 19(2):230-248. PubMed ID: 29460465
[TBL] [Abstract][Full Text] [Related]
13. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gamma index based on dosimetric error and clinically relevant dose-volume index based on three-dimensional dose prediction in breast intensity-modulated radiation therapy.
Kaneko A; Sumida I; Mizuno H; Isohashi F; Suzuki O; Seo Y; Otani K; Tamari K; Ogawa K
Radiat Oncol; 2019 Feb; 14(1):36. PubMed ID: 30808377
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
Jiao SX; Wang ML; Chen LX; Liu XW
Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
[TBL] [Abstract][Full Text] [Related]
16. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
[TBL] [Abstract][Full Text] [Related]
17. A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Yao CY; Zhou GR; Wang LJ; Xu JH; Ye JJ; Zhang LF; He X; Chen ZZ; Huang SF
Radiat Oncol; 2018 Oct; 13(1):194. PubMed ID: 30285884
[TBL] [Abstract][Full Text] [Related]
18. A quality assurance method that utilizes 3D dosimetry and facilitates clinical interpretation.
Oldham M; Thomas A; O'Daniel J; Juang T; Ibbott G; Adamovics J; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):540-6. PubMed ID: 22361085
[TBL] [Abstract][Full Text] [Related]
19. Individual volume-based 3D gamma indices for pretreatment VMAT QA.
Yi J; Han C; Zheng X; Zhou Y; Deng Z; Xie C; Jin X; Jin F
J Appl Clin Med Phys; 2017 May; 18(3):28-36. PubMed ID: 28318101
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
